Titre : Tumeurs de la trachée

Tumeurs de la trachée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de la trachée : Questions médicales les plus fréquentes", "headline": "Tumeurs de la trachée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de la trachée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de la trachée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladie de la trachée", "url": "https://questionsmedicales.fr/mesh/D014133", "about": { "@type": "MedicalCondition", "name": "Maladie de la trachée", "code": { "@type": "MedicalCode", "code": "D014133", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.907" } } }, "about": { "@type": "MedicalCondition", "name": "Tumeurs de la trachée", "alternateName": "Tracheal Neoplasms", "code": { "@type": "MedicalCode", "code": "D014134", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "V D Parshin", "url": "https://questionsmedicales.fr/author/V%20D%20Parshin", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M A Rusakov", "url": "https://questionsmedicales.fr/author/M%20A%20Rusakov", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M S Simonova", "url": "https://questionsmedicales.fr/author/M%20S%20Simonova", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M A Ursov", "url": "https://questionsmedicales.fr/author/M%20A%20Ursov", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "Keiichi Morita", "url": "https://questionsmedicales.fr/author/Keiichi%20Morita", "affiliation": { "@type": "Organization", "name": "Department of Pediatric Surgery, Kobe Children's Hospital, 1-6-7, Minatojima Minami-cho, Chuo-ku, Kobe, 650-0047, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36651430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/acb371205" } }, { "@type": "ScholarlyArticle", "name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36253300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.09.007" } }, { "@type": "ScholarlyArticle", "name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-76355-4" } }, { "@type": "ScholarlyArticle", "name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37271051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmpb.2023.107624" } }, { "@type": "ScholarlyArticle", "name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36917412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03531-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Maladie de la trachée", "item": "https://questionsmedicales.fr/mesh/D014133" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs de la trachée", "item": "https://questionsmedicales.fr/mesh/D014134" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de la trachée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de la trachée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de la trachée", "description": "Comment diagnostique-t-on une tumeur de la trachée ?\nQuels tests sont utilisés pour évaluer la fonction respiratoire ?\nLes examens d'imagerie sont-ils toujours nécessaires ?\nQuels symptômes peuvent indiquer une tumeur trachéale ?\nLa biopsie est-elle toujours requise pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de la trachée", "description": "Quels sont les symptômes courants des tumeurs trachéales ?\nLa voix peut-elle être affectée par une tumeur trachéale ?\nLes symptômes varient-ils selon le type de tumeur ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes symptômes peuvent-ils s'aggraver rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de la trachée", "description": "Peut-on prévenir les tumeurs de la trachée ?\nLe tabagisme est-il un facteur de risque ?\nLes expositions professionnelles peuvent-elles être un risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?\nUne alimentation saine peut-elle aider à prévenir ces tumeurs ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de la trachée", "description": "Quels traitements sont disponibles pour les tumeurs trachéales ?\nLa chirurgie est-elle toujours nécessaire ?\nLa radiothérapie est-elle efficace contre ces tumeurs ?\nQuels sont les effets secondaires des traitements ?\nPeut-on combiner plusieurs traitements ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de la trachée", "description": "Quelles complications peuvent survenir avec ces tumeurs ?\nLes tumeurs trachéales peuvent-elles se propager ?\nComment les complications affectent-elles le traitement ?\nLes infections sont-elles fréquentes avec ces tumeurs ?\nPeut-on prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Prostatic+Neoplasms&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de la trachée", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de tumeurs trachéales ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes infections respiratoires chroniques sont-elles un facteur de risque ?\nLes facteurs environnementaux influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une tumeur de la trachée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (CT, IRM) et bronchoscopie pour biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la fonction respiratoire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire mesurent la capacité respiratoire et l'obstruction." } }, { "@type": "Question", "name": "Les examens d'imagerie sont-ils toujours nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont essentiels pour visualiser la tumeur et son extension." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une tumeur trachéale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, difficultés respiratoires, et stridor peuvent alerter." } }, { "@type": "Question", "name": "La biopsie est-elle toujours requise pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la biopsie confirme la nature bénigne ou maligne de la tumeur." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs trachéales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Toux, dyspnée, stridor, douleur thoracique et hémoptysie sont fréquents." } }, { "@type": "Question", "name": "La voix peut-elle être affectée par une tumeur trachéale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une tumeur peut provoquer des changements de voix ou une dysphonie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer entre tumeurs bénignes et malignes." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans tumeur visible ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même si la tumeur est petite ou cachée." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines tumeurs peuvent croître rapidement et aggraver les symptômes." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs de la trachée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais éviter le tabac aide." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de développer des tumeurs respiratoires." } }, { "@type": "Question", "name": "Les expositions professionnelles peuvent-elles être un risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des substances toxiques peut augmenter le risque de tumeurs." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs trachéales." } }, { "@type": "Question", "name": "Une alimentation saine peut-elle aider à prévenir ces tumeurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de cancer en général." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs trachéales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent la chirurgie, la radiothérapie et la chimiothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, cela dépend de la taille et de la localisation de la tumeur." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace contre ces tumeurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour réduire la taille des tumeurs malignes." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets peuvent inclure fatigue, irritation des voies respiratoires et nausées." } }, { "@type": "Question", "name": "Peut-on combiner plusieurs traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une approche multimodale est souvent utilisée pour optimiser les résultats." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces tumeurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent obstruction des voies respiratoires et infections." } }, { "@type": "Question", "name": "Les tumeurs trachéales peuvent-elles se propager ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent envahir les tissus voisins ou se propager à d'autres organes." } }, { "@type": "Question", "name": "Comment les complications affectent-elles le traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent compliquer le traitement et nécessiter des interventions supplémentaires." } }, { "@type": "Question", "name": "Les infections sont-elles fréquentes avec ces tumeurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections respiratoires peuvent survenir en raison de l'obstruction." } }, { "@type": "Question", "name": "Peut-on prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un suivi médical régulier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des produits chimiques et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de tumeurs trachéales ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 50 ans." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer ou de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les infections respiratoires chroniques sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent prédisposer à des tumeurs trachéales." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la pollution de l'air et l'exposition à des irritants augmentent le risque." } } ] } ] }

Sources (10000 au total)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat... Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus.... Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ... There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....

Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.

In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals.... This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ... It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high... As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.

With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di... We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ... An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve... This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n... The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit... In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ... A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.

Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o... PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u... More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ... Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....

Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga... Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu... Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114... The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...